Creating quick tests for bacterial vaginosis using small molecule biomarkers
Official title: Development of Small Molecule Biomarker-Based Diagnostics for Bacterial Vaginosis
Funded at Metabolitedx Corp · NIH-10822620 · Data updated 2026-11-12
This study is working on a quick and easy test to help women find out if they have bacterial vaginosis (BV) by looking for specific markers in vaginal fluid, so they can get the right treatment faster without needing complicated lab tests.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Metabolitedx Corp NIH-funded |
| Lab location | 1 site (Redmond, United States) |
| Project start | February 1, 2024 |
| Project end | January 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $306,500 |
| NIH project number | 1R41AI176963-01A1 |
| Project ID | NIH-10822620 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women of reproductive age who experience symptoms of bacterial vaginosis.
✕Less likely to help
Patients who do not have bacterial vaginosis or are not assigned female at birth may not benefit from this research.
What this research studies
This research focuses on developing a rapid diagnostic test for bacterial vaginosis (BV), a common vaginal infection affecting many women. The approach involves identifying small molecule metabolites in vaginal fluid that can serve as biomarkers for BV, allowing for quicker and more accurate diagnosis at the point of care. By utilizing advanced molecular detection techniques, the goal is to create a test that is sensitive, specific, and easy to use, reducing the reliance on complex laboratory procedures. This could significantly improve the management of BV by enabling timely treatment.
Why it matters
Potential benefit: If successful, this research could provide women with a fast and accurate way to diagnose bacterial vaginosis, leading to quicker treatment and better health outcomes.
How similar studies have gone: Other research has shown promise in using metabolite biomarkers for diagnostics, indicating that this approach could be effective.
Where this research is happening
-
Metabolitedx Corp
Redmond, United States Active
Researchers
- Principal investigator: Srinivasan, Sujatha — Metabolitedx Corp
- Study coordinator: Srinivasan, Sujatha
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.